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Background: Because neither the incidence and risk factors for rhabdomyolysis in the ICU nor the dynamics of its
main complication, i.e., rhabdomyolysis-induced acute kidney injury (AKI) are well known, we retrospectively studied
a large population of adult ICU patients (n = 1,769).
Methods: CK and sMb (serum myoglobin) and uMb (urinary myoglobin) were studied as markers of rhabdomyolysis
and AKI (RIFLE criteria). Hemodialysis and mortality were used as outcome variables.
Results: Prolonged surgery, trauma, and vascular occlusions are associated with increasing CK values. CK correlates
with sMb (p < 0.001) and peaks significantly later than sMb or uMb.
The logistic regression showed a positive correlation between CK and the development of AKI, with an OR of 2.21.
Univariate logistic regression suggests that elevations of sMb and uMb are associated with the development of AKI,
with odds ratios of 7.87 and 1.61 respectively. The ROC curve showed that for all three markers a significant
correlation with AKI, for sMb with the greatest area under the curve. The best cutoff values for prediction of AKI were
CK > 773 U/l; sMb > 368 μg/l and uMb > 38 μg/l respectively.
Conclusions: Because it also has extrarenal elimination kinetics, our data suggest that measuring myoglobin in
patients at risk for rhabdomyolysis in the ICU may be useful.
Keywords: Rhabdomyolysis, Intensive care unit–ICU, Creatine kinase, Creatine phosphokinase, Myoglobin, Serum
myoglobin, Urinary myoglobin, Acute kidney injuryBackground
Rhabdomyolysis is a syndrome that is characterized by
the disintegration of striated muscle and the leakage of
intracellular muscular components into the blood and
urine. It results in electrolyte disturbances and an eleva-
tion in the levels of sarcolemmal proteins, such as creat-
ine kinase (CK) and myoglobin in body fluids [1,2].
The presentation of this multifactorial and multicausal
syndrome varies from an asymptomatic but detectable
elevation of CK and myoglobin in blood to a life-
threatening condition with fulminant acute renal failure.
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reproduction in any medium, provided the origkidney injury (AKI) is critical, because rhabdomyolysis
is thought to be one of the leading causes of AKI. In-
deed, 10–50% of patients with some degree of marked
rhabdomyolysis develop AKI, and it has been suggested
that rhabdomyolysis contributes to 5–25% of all cases
of AKI [3].
The pathophysiology of rhabdomyolysis-induced AKI
is believed to be triggered predominantly by myoglobin,
which may cause renal dysfunction by direct renal cyto-
toxicity after reaching the tubules [4], vasoconstriction
and tubular obstruction [1,5]. CK is the marker most
commonly used to guide the diagnosis and therapy in
daily clinical practice. Its half-life is 1.5 days [3]. In con-
trast, myoglobin is cleared much more quickly (half-life
2–3 hours), and clearance also occurs outside of the kid-
ney [1]. The CK level that is associated with an increaseds is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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5,000 U/L have been reported to increase the risk of
rhabdomyolysis-induced AKI [6], especially when acid-
osis is present concomitantly [2,7]. Because most rhabdo-
myolysis studies are retrospective and involve small
sample sizes, the exact role of myoglobin in the progres-
sion of the condition and the levels that lead to renal tox-
icity in rhabdomyolysis are still unclear [1,8-10].
Critically ill patients admitted to the intensive care
unit (ICU) are at particular risk for rhabdomyolysis. In-
deed, many of the known risk factors for rhabdomyoly-
sis, including hypotension [1], trauma [6], electrolyte
disturbances [11], drug abuse [12] and sepsis [13], occur
commonly and often concomitantly in patients admitted
to the ICU. Therefore, we studied a large number of pa-
tients in our ICU in whom serum CK and myoglobin
(sMb) values as well as urinary myoglobin (uMb) levels
were available. This large database allowed us to evaluate
rhabdomyolysis risk factors in addition to the patho-
physiological roles and predictive values of CK and myo-
globin in the most important rhabdomyolysis-induced
complication in the ICU environment: AKI.
Methods
Patients
This study was a single-center, retrospective, observa-
tional cohort study in the ICU of Antwerp University
Hospital (Edegem, Belgium), the tertiary referral centre
of the University of Antwerp. All adults who were admit-
ted to our intensive care unit (which cares for both med-
ical and surgical patients) during a period of 15 months
(June 2008 to September 2009) were eligible for enrol-
ment and retrospective evaluation. Because we sought
cases of real rhabdomyolysis, we excluded patients ad-
mitted with elevated CK levels due to a myocardial in-
farction or acute coronary syndrome (ACS). Patients
with a cerebral vascular infarction (CVA) or bleeding
also were excluded, because damage to cerebral tissue
can give rise to plasma CK-BB isoenzyme levels. More-
over, patients on chronic dialysis were excluded, be-
cause the outcome measures of AKI could not be
objectively assessed.
Procedures and data collection
This observational study without any specific interven-
tion was reviewed and approved by the hospital’s Institu-
tional Review Board (Reference number EC110219), and
all data were anonymously processed. Informed consent
was not required, because this was not an interventional
study; however, all patients and families were informed
on the admission leaflet that anonymous data may be
used for academic research. In addition to serial bio-
chemical and hematological laboratory data, several
pieces of data were obtained for each patient. In ourcenter, baseline muscular injury markers (CK, sMb, and
uMb) are measured on admission to assess the break-
down of striated muscle, and troponin-I to assess cardiac
muscle damage. Myoglobin levels in serum and urine
(reported as μg/l) are determined with on immunoassay
on an Access 2 immunoassay from Beckman Coulter
(Analis, Suarlée, Belgium) using reagents of the same
manufacturer. The baseline serum creatinine value was
the creatinine obtained on admission in the ICU; the
peak creatinine value was considered as the highest level
during the ICU stay and therefore compared with the
serum creatinine on admission.
Creatinine, CK, and Mb were always measured at the
same time point, at least daily. If oliguria was present,
uMb could of course not be measured. The uMb level in
these patients was considered as missing value and not
included in the statistical analysis.
In our ICU, blood is obtained in our patients on admis-
sion and at least daily (6 am) for the subsequent 72 hours
unless the patient is discharged or deceased prior to that
time. If CK is at least “moderately” elevated after 72 hours
(CK level > 1,000 U/L), markers of muscular injury are
usually followed daily until normalization of CK below
the 1,000 U/l level. The following data were obtained: ad-
mission and maximum laboratory values that are rou-
tinely assessed daily in the ICU; demographic and clinical
information, including age, gender, vital parameters
(mean blood pressure and Pa02 on admission); length of
stay at the ICU and information necessary to determine
the severity of organ failure, including the SOFA score
(Sequential Organ Failure Assessment score [14]). On
this scale, higher scores indicate more severe illness and
a higher number of therapeutic interventions. Moreover,
the inotropic index as a validated marker for the degree
of hemodynamic support was calculated for each individ-
ual patient [15].
We systematically looked for risk factors for rhabdo-
myolysis as reported in the literature. Rhabdomyolysis is
most commonly caused by direct physical trauma to skel-
etal muscle as a result of crush injury, extreme exercise, or
seizures. Muscular ischemia is associated with rhabdo-
myolysis, most likely due to reperfusion injury after the
restoration of adequate blood flow. Other causes include
hereditary disorders, such as carnitine palmitoyltransferase
II deficiency, malignant hyperthermia, and inflammatory
disorders, such as dermatomyositis and polymyositis [1].
Prolonged surgery was arbitrarily defined as surgery for
longer than 6 hours of duration, before ICU admission.
Risk factors were considered relevant if they had occurred
in the 24 hours before admission to the ICU.
Admission for fulminant rhabdomyolysis has been as-
sociated with the use of medication and illegal drugs [1].
HMG-CoA reductase inhibitors, fibrates, and diuretics
are the agents most commonly associated with drug-
Table 1 Patient characteristics and outcomes in the ICU
Creatine kinase
(U/L)
<170 170–999 1,000–5,000 >5,000
Count (n) 398 1029 283 59
Gender: men (%) 212 (53.9%) 676 (66.3%) 192 (68.6%)* 45 (77.6%)*
Age 65 (53–73) 66 (55–74) 62 (50–71) 63 (46–71)
ICU stay (days) 2 (1–6) 2 (1–4) 3 (1–9)* 6 (3–14)*
SOFA 5 (2–8) 6 (4–9) 7 (4–10)* 9 (5–13)*
AKI (%) 56 (14.1%) 181 (17.5%) 83 (29.3%)* 25 (42.4%)*
Hemodialysis (%) 34 (8.5%) 56 (5.4%) 33 (11.7%) 25 (42.4%)*
Mortality (%) 35 (8.8%) 51 (5%) 33 (11.7%) 16 (27.1%)*
Data are presented as median (Q1 - Q3).
AKI, acute kidney injury; ICU, intensive care unit.
*p < 0.05 compared with the group with normal CK levels (<170 U/L).
El-Abdellati et al. Annals of Intensive Care 2013, 3:8 Page 3 of 8
http://www.annalsofintensivecare.com/content/3/1/8induced rhabdomyolysis, and we evaluated the patients
for systemic evidence of these medications [1,16,17]. We
also screened for the use of toxic substances including
ethanol, cocaine, and amphetamine, because these also
are important causes of rhabdomyolysis [1,12,18,19].
The abuse of ethanol is specifically asked to every pa-
tient or his or her family upon admission in our ICU.
Numerical data were extracted from the patient data
management system (PDMS system, IMD soft, Metavision)
by a senior ICU staff member who was blinded to the pa-
tient’s rhabdomyolysis status. All other data were retrieved
using an electronically prepared data acquisition form.
These data were reviewed for missing information, logical
errors, insufficient detail, or the need for additional queries
and were analyzed by statistical software (Statistical
Package for the Social Sciences, SPSS Inc., version 19). Pa-
tients were excluded from the analysis if the myoglobin
values were not available.
Specific outcome measures of renal failure
Complications and outcomes (AKI, need for dialysis and
mortality) were recorded for each patient. AKI was de-
fined using the RIFLE criteria with a minimum of 50%
increase over baseline creatinine values. The acronym
RIFLE stands for the increasing severity classes, risk (R) = 1,
injury (I) = 2, and failure (F) = 3, and the two outcome clas-
ses, loss (L), and end-stage kidney disease (E). These criteria
have been validated for ICU patients, such as those in our
sample [20].
Statistical analysis
All analyses were done in SPSS 19 (IBM, New York) and
SAS 9.2 (SAS Institute, Cary, NC). Data are presented as
median values with their lower and upper quartiles. Be-
cause CK, sMb, and uMb turned out to be log-normally
distributed, log-transformations of these parameters will
be used in all analyses.
The CK values were divided in four subgroups: 1) nor-
mal values with a maximum of 170 U/L; 2) between
170–1,000 U/l (moderately elevated up to more than five
times the cutoff value); 3) between 1,000–5,000 IU/l;
and 4) >5,000 U/L. These values were chosen because
many clinicians use five times the upper limit of normal
CK (approximately 850–1,000 U/l) as a reference point
[21], whereas CK values of 5,000 U/L and higher are
thought to be associated with an increased risk of
rhabdomyolysis-induced AKI [6]. The subclass of
values >5,000 was not divided further as hardly any
patients presented with values >10,000 IU/l.
Patient characteristics are compared between these
four CK groups by means of Kruskal-Wallis tests with
subsequent post hoc analysis and Dunnett’s correction
for multiple testing. For categorical variables, chi-square
testing was used.CK, sMb, and uMb are compared between RIFLE
groups using ANOVA and post hoc analyses on the log-
transformed values. Correlations between CK peak, sMb
peak, and uMb peak, and their timing are assessed with
Spearman correlation coefficients. Wilcoxon signed-rank
tests were used to detect differences in timing.
Separate multiple logistic regression models were
build to predict the development of AKI, with CK,
sMb, and uMb as explanatory variables, taking into ac-
count other risk factors: baseline mean blood pressure,
creatinine, CK, sMb, uMb, arterial Pa02 on admission,
lactate, osmolarity, SOFA, use of loop diuretics, pres-
ence of sepsis, hours of surgery exceeding 6, muscle is-
chemia, trauma, inotropic index, and the need for
mechanical ventilation. For each of these models, ROC
curves and their area under the curve are studied to
evaluate the diagnostic performance of CK, sMb, and
uMb. Cutoff values for CK, sMb, and UMb were calcu-
lated based on the ROC curve corresponding to the
simple logistic regression models. With these cutoff
values, a new multiple logistic regression model is built
to study the effect of combined elevation (above cutoff )
of CK and sMb.
Statistical significance was considered at the level
of p < 0.05 for all comparisons.
Results
Global patient characteristics
A total of 2,699 adult patients were admitted to the ICU
during the study period, and 1,769 patients were eligible
for further evaluation. After the omission of patients
with ACS (n = 179), CVA (n = 113), or on chronic dialy-
sis (n = 40), the most common reasons for exclusion
were missing myoglobin levels in either serum or urine.
None of the included patients had received forced diur-
esis, mannitol, or bicarbonate as a preventive measure
when CK elevation was seen. Table 1 displays the patient
characteristics for every subgroup of CK values.
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A total of 342 patients (20.4%) had CK values greater
than 1,000 U/L. The SOFA score and outcomes (inci-
dence of AKI, hemodialysis, and mortality) were signifi-
cantly associated with increasing CK category (Table 1).
In patients with highly elevated CK values (defined as
>5,000 IU/l), hemodialysis was necessary in up to 42.4%
of these patients and a mortality rate of 27.1% was ob-
served in this group.
The etiologies of the observed CK elevations are
displayed in Table 2. There were significant associations
between CK levels greater than 5,000 U/L and recent
(orthopedic) surgery. Trauma, resuscitation, compart-
ment syndrome, and prolonged surgery for more
than 6 hours also were observed more frequently in
the same subgroup group with CK levels >5,000 U/L
(Table 2).Table 2 Etiology of elevated CK values in the ICU
CK (U/L) <170 (%) (n = 398) 170–999 (%








Muscle ischemia 9.5 12.9
Arterial occlusion 5 3.7
Venous occlusion 1.6 2.4
Compartment syndrome 0 1.1*
Immobilization 1.6 1.5
Prolonged surgery 1.3 4.5*
Resuscitation 5.3 6.3
Trauma 2.4 7.5*
Blunt trauma 2.1 7.1*
Penetrating trauma 0.5 1.1
Infectious 48.8 52.4
Severe sepsis and septic shock 10.6 9.7
Necrotizing fasciitis 0.3 0.4
Gram-positive infection 12.5 8.6
Gram-negative infection 25.7 18.8





Data are presented as %.
*p < 0.05 (statistically significant compared with the CK level <170 U/l).
Immobilization = before admission; Prolonged surgery = surgery for more than 6 ho
All risk factors were considered relevant if they had occurred in the 24 hours beforeTable 3 displays the mean peak CK, sMb, and uMb
values with their corresponding p values for the different
RIFLE groups. This table shows that patients who later
develop AKI (RIFLE criteria 2 and 3) have significantly
higher uMb, sMb, and CK values compared with RIFLE
criterion 0. Our results also show a positive correlation
between sMb and CK (r = 0.714, p < 0.001), but CK
peaked significantly later than sMb (72 hours ± 145 SD
vs. 30 hours ± 87 SD, p < 0.001) and uMb (72 hours ±
145 SD vs. 33 hours ± 77 SD, p < 0.001) values. There
was a positive correlation between the timing of the CK
peak and sMb peak (r = 0.304, p < 0.001) and between
the timing of the CK peak and the uMb peak (r = 0.239,
p < 0.001).
The logistic regression model with log-transformed
CK values in Table 4 showed a positive correlation with






























admission to the ICU.
Table 3 Peak levels of CK and Mb according to the occurrence of acute kidney injury (RIFLE criteria used)
RIFLE-criteria None Risk Injury Failure
Number (%) 1,440 (81.4%) 171 (9.7%) 75 (4.2%) 83 (4.7%)
CK (U/l) 433 (186–744) 474 (257–869) 669 (439–1415)* 873 (410–2669)*
sMb (μg/l) 228 (107–444) 362 (158–764)* 617 (204–1382)* 740 (255–2349)*
uMb (μg/l) 9 (9–66) 17 (9–372)* 11 (9–341)* 58 (9–431)*
Data presented as median (Q1 - Q3).
*p < 0.05 compared with the group with RIFLE = 0, test on log-transformed CK, sMb, and uMb.
sMb, serum myoglobin; uMb, urinary myoglobin; CK, creatine kinase.
RIFLE : R(isk) = 1, I(njury) = 2, F(ailure) = 3, L(oss), E(nd stage).
El-Abdellati et al. Annals of Intensive Care 2013, 3:8 Page 5 of 8
http://www.annalsofintensivecare.com/content/3/1/8(confidence interval (CI) 1.45–3.38, p = 0.0002). Elevations
of sMb and uMb are associated with the development of
AKI, with ORs of 7.87 (CI 4.6–13.85, p < 0.0001) and 1.61
(CI 1.21–2.13, p = 0.001) respectively.
When omitting the patients who died within 24 hours
(n = 29) or 48 hours (n = 39) after admission in the ICU,
neither the OR nor the area under the ROC curve
changed. Moreover, this also was true when correcting
the model for those patients discharged from the ICU
within 24 hours (n = 676) and 48 hours (n = 938) re-
spectively (data not shown). Only when performing the
subgroup analysis by omitting patients hospitalized up
to 24 hours (not 48 hours) in the ICU, the correlation
between the development of AKI and uMb disappeared
(data not shown).
Although for all three parameters (CK, sMb, uMb)
there is a significant correlation with AKI, ROC curves
(Figure 1) show that sMb has the greatest area under the
curve and can therefore give the best prediction for AKI.
The best cutoff values for prediction of AKI, based on in-
dividual ROC curves, were CK > 773 U/l, sMb > 368 μg/l,
and uMb > 38 μg/l, respectively. Table 5 displays the results
of combining the cutoff values for CK and sMb in an add-
itional logistic regression model, taking into account theTable 4 Odds ratios for the development of acute kidney
injury
Models corrected for known risk
factors*
95% conf int Area
under
OR Lower Upper P value ROC
Curve
Log10 Creatine kinase 2.21 1.45 3.38 0.0002 0.759
Log10 Serum Myoglobin 7.87 4.60 13.85 < 0.0001 0.790
Log10 Urinary Myoglobin 1.61 1.21 2.13 0.0010 0.766
CK 170 - 1000 U/L** 1.42 0.84 2.45 0.1979
CK 1000 - 5000 U/L** 2.56 1.27 5.21 0.0087
CK > 5000 U/L** 5.12 1.84 14.29 0.0018
*Risk factors at baseline: mean blood pressure, creatinine, CK, sMb, uMb, PaO2,
lactate, osmolarity, SOFA, use of loop diuretics, sepsis, hours of surgery > 6,
inotropic index, mechanical ventilation, trauma and muscle ischemia.
**The different CK categories are compared with reference CK < 170 U/L.other risk factors. It clearly shows that an elevated CK
value alone, with sMb below the cutoff, does not lead to an
increased risk for AKI (p = 0.8818). On the other hand, an
elevation in sMb > 368 μg/l significantly increases the risk
of AKI, regardless of CK elevation (OR respectively 4.3 and
5.1, p < 0.0001).
Discussion
A limited number of observational and retrospective stud-
ies have examined the occurrence of rhabdomyolysis in
critically ill patients in either the ICU [6,10] or the emer-
gency department [22]. De Meijer and coworkers reported
in another retrospective study that severe rhabdomyolysis,
defined primarily on the basis of elevated serum CK levels
of even greater than 10,000 U/l at some time during
hospitalization in the ICU, was observed in 71 of 7,500 pa-
tients admitted over a long period [10]. Our observationalFigure 1 ROC curve: predictive value of creatine kinase,
serum and urinary myoglobin. All three markers show significant
correlation with acute kidney injury. Serum myoglobin has clearly the
best predictive value. CK, creatine kinase; sMb, serum myoglobin; uMb,
urinary myoglobin; cat, categorical (CK <170 U/L, CK 170–1,000 U/L,
CK 1,000–5,000 U/L and CK >5,000 U/L).
Table 5 Odds ratios for the development of acute kidney
injury when CK and/or sMb are above their cutoff values
(based on ROC curves)
Model corrected for known risk factors*
95% confidence interval
OR Lower Upper p value**
CK > 773, sMb ≤ 368 1.06 0.45 2.27 0.8818
CK ≤ 773, sMb > 368 4.29 2.71 6.8 <0.0001
CK > 773, sMb > 368 5.11 3.03 8.63 <0.0001
*Risk factors at baseline: mean blood pressure, creatinine, CK, sMb, uMb, PaO2,
lactate, osmolarity, SOFA, use of loop diuretics, sepsis, hours of surgery > 6,
inotropic index, mechanical ventilation, trauma and muscle ischemia.
**p value compared with the reference group CK ≤ 773 U/l and sMb ≤ 368 μg/l.
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rhabdomyolysis (elevated levels of CK and/or myoglobin)
are frequently observed in patients admitted to the ICU.
The underlying causes of severe rhabdomyolysis have
reported as being highly variable: ischemia by vascular ob-
struction and trauma (not commonly seen), sepsis and
heatstroke/hypothermia in three patients each (11.5%) and
hyponatremia in a single patient [10]. Vascular disease and
trauma, known risk factors [3,7,10], also were determined
to be contributing factors in our study. The causes of
elevated CK and myoglobin levels in our study also were
variable, but a primary cause seemed to be recent sur-
gery (p < 0.001), especially prolonged surgery, in agree-
ment with previous observations [23]. The other known
reported etiologies of rhabdomyolysis, such as alcohol
abuse [22], were not observed as important causal fac-
tors in our data. Of all known drugs reported to cause
rhabdomyolysis, loop diuretics exposure before admission
was the only drug associated with a marked CK eleva-
tion in our center. A limited number of patients were
admitted to our ICU for alcohol or drug poisoning and
polytrauma during this particular study period, which
might have been responsible for the absence of these
specific risk factors in our study.
Studies on rhabdomyolysis usually cover a wide disease
spectrum with diverse etiologies, dissimilar diagnostic
criteria for AKI and rhabdomyolysis, various methods,
and differences in sample collection and decision cutoff
values [24]. Furthermore, CK is generally considered
the best overall parameter to determine the risk for
development of its main complication AKI, whereas
myoglobin is actually the main causative protein for
developing AKI-associated rhabdomyolysis [1]. More-
over, most studies only analyze urinary myoglobin
qualitatively using a dipstick method, which does not
reliably differentiate between hemoglobin, myoglobin,
and red blood cells [24]. Due to the retrospective na-
ture of most studies on rhabdomyolysis in general and,
especially, in the ICU setting, as well as the small sample
sizes generally involved in these studies, the role of themuscular proteins in rhabdomyolysis and relevant serum
values are still unclear. We therefore studied more than
1,700 patients to enable us to evaluate the role of CK,
sMb, and uMb in rhabdomyolysis-induced AKI.
AKI has been defined differently in the studies that
have investigated the relationship between CK and
myoglobin levels and AKI. Some authors define AKI
as a decline in renal function to such an extent as any
form of renal replacement therapy is necessary [10].
Brown and coworkers defined AKI as a peak creatinine
of 2.0 mg/dl [6], whereas we used the consistent and
more recent RIFLE criteria with a minimum of 50%
increase in baseline creatinine values [20]. Although
previous studies [6,10] and reviews [2,3] suggest that a
CK level of either >5,000 U/L or 10,000 U/L is associ-
ated with a higher rate of renal failure, we demon-
strate by using a logistic regression model and ORs
that a CK level of more than 1,000 U/L is associated
with almost a threefold increased odds for developing
AKI in the ICU compared with the group with normal
CK values. Furthermore, our data indicate that a CK
level of >5,000 U/L is even associated with an odds ra-
tio of 5.1 for developing AKI.
Although myoglobin is thought as the single most im-
portant cause of rhabdomyolysis-induced AKI [2], only
studies with small sample sizes are available to explore
this hypothesis [24]. In our study, there is a strong cor-
relation between sMb and CK. sMb peaks significantly
earlier than CK (30 vs. 72 hours), which also is true for
uMb (33 vs. 72 hours). These results are in agreement
with previous observations that demonstrated a peak in
myoglobin concentration before peaks in CK following
muscular injury [8,9,25]. Myoglobin is not routinely
assessed in all centers as it is at our site. The availabil-
ity of serum myoglobin in our hospital as a more or
less routine marker as well as the turnaround time of
less than 90 minutes from taking the blood sample
until the validated value is available is a rather unique
situation compared with most other ICUs. Further-
more, myoglobin also is available as a point-of-care
test with a turnaround time of less than 20 minutes in
our emergency department.
The interpretation of results also is hampered by un-
predictable renal and hepatic elimination of plasma
myoglobin, and published correlation with the degree of
myoglobinemia is poor. Therefore, although myoglobin
is known to play a role in kidney injury, serum levels of
CK are usually monitored to guide therapy [8]. We re-
port that myoglobin has a strong correlation with AKI
and CK in the ICU, and it peaks significantly earlier than
CK. The quantitative evaluation of myoglobin is not
overly expensive and can provide timely and valuable in-
formation regarding the development of AKI in the ICU
setting. As other authors have suggested, the initiation
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alone or in addition to CK [8,25,26]. In a small group of
30 ICU patients with massive rhabdomyolysis, receiver
operating characteristic analysis showed that the AUC
for blood myoglobin that predicted acute renal failure
was 0.88, and the best cutoff value for blood myoglobin
was 3865 μg/l [26]. The cutoff values in our study were
773 U/l for CK and 368 μg/l for sMb respectively. This
much lower cutoff value for Mb can be explained by the
much larger group in our study as well as the use of val-
idated RIFLE criteria as opposed to creatinine change
only. Because myoglobin is eliminated quickly and elim-
ination occurs outside of the renal system [8,9,26], our
data indicate that routinely measuring myoglobin on
admission and, subsequently, in patients at risk of de-
veloping rhabdomyolysis in the ICU setting might be
of clinical value.
There are some limitations to using myoglobin as a
predictor of AKI. SMb and uMb are not routinely avail-
able and are only performed in many institutions when
CK has been shown to be markedly elevated. In addition
to the fast elimination kinetics, there is a large overlap
of mean myoglobin values, which makes laboratory data
difficult to interpret. However, this overlap also is
present in the mean CK value in each different RIFLE
group (Table 3). The mean values for CK and urinary
myoglobin of the relatively more severe cases (RIFLE
group 2 (I) and 3 (F) differ significantly from the non-
AKI group. Nevertheless, the large standard deviation
makes it difficult to interpret single case values in clin-
ical practice. The risk profile of the patient and the ORs
for CK, sMb, and uMb can help to evaluate these
patients.
Although this is a large study on rhabdomyolysis in
the ICU, some limitations should be taken into account.
To ensure the quality of this retrospective observational
study, some patients had to be excluded. Up to 38% of
the patients in the primary study group were excluded
because their admission diagnosis was known to cause
CK elevations or based on the absence of complete myo-
globin data, leading to a certain degree of bias. We are
convinced that our data reflect “real life” in the ICU as
excluding the patients who died soon after their admis-
sion to the ICU or who only stayed for a “short” period
(up to 48 hours) had no influence on the analysis of the
outcome parameters. Moreover, the kinetics of myoglo-
bin release might vary between patients and myoglobin
was only available at one time point each day: real peak
values might therefore be missed as measuring the exact
peak values might imply a more frequent sampling para-
digm. Blood and urine sampling was performed daily at
24-hour intervals with some patients therefore having
only two samples performed. This lends itself to the pos-
sibility of underestimating the peak serum myoglobin(i.e., marker may rise and fall between the sampling
period) and furthermore the possibility of missing sec-
ondary peaks in the event of a secondary insult.
The contribution of certain risk factors is difficult to
assess. Alcohol abuse is systematically questioned in
our unit, but neither the determination of ethanol levels
nor a drug screening is routinely performed upon admis-
sion, therefore certainly leading to an underestimation of
their real contribution. In addition, we used the RIFLE
criteria to define AKI. These criteria also are based on
creatinine values. Creatinine itself is an intramuscular
component that is associated with a more rapid increase
in rhabdomyolysis-induced AKI than other causes of
AKI [2]. However, the RIFLE criteria are validated in the
ICU, which is relevant for our patient population [20].
Future studies therefore could use biomarkers of cellu-
lar kidney injury to look for early and subtle kidney
damage.
This study was noninterventional and tried to predict
which patients have an increased risk for developing
AKI, but it does not suggest when and which therapy
should be initiated. Therefore, there is a great need for
prospective studies on this subject to evaluate the roles
of CK, uMb, sMb, and the effect of therapy on
preventing rhabdomyolysis-induced AKI. However if a
prospective study was to be planned, myoglobin sam-
pling ideally would be performed more frequently.Conclusions
Our study demonstrates that muscle injury or rhabdo-
myolysis is frequently observed in patients admitted to
the ICU, and this seems to contribute to AKI. Previous
surgery, and especially prolonged surgery, was recog-
nized as the main causal factor. Moreover, sMb and
uMb levels show significant positive ORs for predicting
AKI and peak significant earlier than CK. These data,
the underlying pathophysiological role of myoglobin,
and the relatively low cost of evaluating myoglobin levels
lead us to suggest that myoglobin could be assessed
more routinely in the ICU in patients at risk for devel-
oping AKI. Further studies are necessary to evaluate the
roles of CK, uMb, and sMb and the effect of therapy on
preventing rhabdomyolysis-induced AKI.Abbreviations
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